gender affirming hormone therapy

DRUG2 trials

Sponsors

Medical University of Vienna, Celia Bañuls

Conditions

Gender DysphoriaTransgender

Unknown Phase

Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content

RecruitingNCT06245681

Medical University of ViennaGender Dysphoria

Start: 2017-10-20End: 2028-10-20Target: 40Updated: 2025-10-03

Body Composition Assessment in Transgender Population.

CompletedNCT07481942

Celia BañulsTransgender

Start: 2017-01-01End: 2025-10-31Updated: 2026-03-23

Related Papers

Gender-affirming hormone therapy and its impact on myocardial mass and cardiac function: a prospective magnetic resonance cohort study on transgender men and women

European Journal of Endocrinology2025-03-271 citations